tiprankstipranks
Sinopharm Group Co (SHTDY)
OTHER OTC:SHTDY
Holding SHTDY?
Track your performance easily

Sinopharm Group Co (SHTDY) Financial Statements

21 Followers

Sinopharm Group Co Financial Overview

Sinopharm Group Co's market cap is currently ―. The company's EPS TTM is $1.918; its P/E ratio is 6.94; and it has a dividend yield of 3.85%. Sinopharm Group Co is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue¥ 261.47B¥ 521.05B¥ 249.12B¥ 456.41B¥ 203.76B
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 32.15B¥ 43.54B¥ 34.36B¥ 50.22B¥ 39.36B
Total Assets¥ 370.18B¥ 335.41B¥ 344.33B¥ 311.24B¥ 306.33B
Total Debt¥ 91.90B¥ 68.37B¥ 86.79B¥ 68.53B¥ 88.23B
Net Debt¥ 59.76B¥ 24.83B¥ 52.43B¥ 18.31B¥ 48.87B
Total Liabilities-----
Stockholders Equity¥ 63.24B¥ 61.89B¥ 57.79B¥ 56.36B¥ 51.97B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow¥ -34.29B¥ 9.31B¥ -27.77B¥ 11.15B¥ -27.60B
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Sinopharm Group Co Earnings and Revenue History

Sinopharm Group Co Debt to Assets

Sinopharm Group Co Cash Flow

Sinopharm Group Co Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis